Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Human Immunodeficiency Virus | Research

HIV and hepatitis B, C co-infection and correlates of HIV infection among men who have sex with men in Rwanda, 2021: a respondent-driven sampling, cross-sectional study

Authors: Eric Remera, Elysee Tuyishime, Catherine Kayitesi, Samuel S. Malamba, Beata Sangwayire, Justine Umutesi, Horacio Ruisenor-Escudero, Tom Oluoch

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

Men who have sex with men (MSM) are a key population group disproportionately affected by HIV and other sexually transmitted infections (STIs) worldwide. In Rwanda, the HIV epidemic remains a significant public health concern, and understanding the burden of HIV and hepatitis B and C coinfections among MSM is crucial for designing effective prevention and control strategies. This study aims to determine the prevalence of HIV, hepatitis B, and hepatitis C infections among MSM in Rwanda and identify correlates associated with HIV infection within this population.

Methods

We used respondent-driven sampling (RDS) to recruit participants between November and December 2021. A face-to-face, structured questionnaire was administered. Testing for HIV infection followed the national algorithm using two rapid tests: Alere Combo and STAT PAK as the first and second screening tests, respectively. Hepatitis B surface antigen (HBsAg) and anti-HCV tests were performed. All statistics were adjusted for RDS design, and a multivariable logistic regression model was constructed to identify factors associated with HIV infection.

Results

The prevalence of HIV among MSM was 6·9% (95% CI: 5·5–8·6), and among HIV-positive MSM, 12·9% (95% CI: 5·5–27·3) were recently infected. The prevalence of hepatitis B and C was 4·2% (95% CI: 3·0–5·7) and 0·7% (95% CI: 0·4–1·2), respectively. HIV and hepatitis B virus coinfection was 0·5% (95% CI: 0·2–1·1), whereas HIV and hepatitis C coinfection was 0·1% (95% CI: 0·0–0·5), and no coinfection for all three viruses was observed. MSM groups with an increased risk of HIV infection included those who ever suffered violence or abuse because of having sex with other men (AOR: 3·42; 95% CI: 1·87–6·25), those who refused to answer the question asking about ‘ever been paid money, goods, or services for sex’ (AOR: 10·4; 95% CI: 3·30–32·84), and those not consistently using condoms (AOR: 3·15; 95% CI: 1·31–7·60).

Conclusion

The findings suggest more targeted prevention and treatment approaches and underscore the importance of addressing structural and behavioral factors contributing to HIV vulnerability, setting interventions to reduce violence and abuse against MSM, promoting safe and consensual sexual practices, and expanding access to HIV prevention tools such as condoms and preexposure prophylaxis (PrEP).
Literature
1.
go back to reference Birx D, Zaidi I. Forward: Measuring Progress Toward Epidemic Control. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2021;87:S1.CrossRefPubMed Birx D, Zaidi I. Forward: Measuring Progress Toward Epidemic Control. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2021;87:S1.CrossRefPubMed
2.
3.
go back to reference Lee BX, Kjaerulf F, Turner S, Cohen L, Donnelly PD, Muggah R, et al. Transforming our world: implementing the 2030 agenda through sustainable development goal indicators. J Public Health Policy. 2016;37:13–31.CrossRefPubMed Lee BX, Kjaerulf F, Turner S, Cohen L, Donnelly PD, Muggah R, et al. Transforming our world: implementing the 2030 agenda through sustainable development goal indicators. J Public Health Policy. 2016;37:13–31.CrossRefPubMed
5.
go back to reference Baral S, Sifakis F, Cleghorn F, Beyrer C. Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000–2006: a systematic review. PLoS Med. 2007;4(12): e339.CrossRefPubMedPubMedCentral Baral S, Sifakis F, Cleghorn F, Beyrer C. Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000–2006: a systematic review. PLoS Med. 2007;4(12): e339.CrossRefPubMedPubMedCentral
6.
go back to reference Chipanta D, Pettifor A, Edwards J, Giovenco D, Topazian HM, Bray RM, et al. Access to social protection by people living with, at risk of, or affected by HIV in Eswatini, Malawi, Tanzania, and Zambia: Results from population-based HIV impact assessments. AIDS Behav. 2022;26(9):3068–78.CrossRefPubMedPubMedCentral Chipanta D, Pettifor A, Edwards J, Giovenco D, Topazian HM, Bray RM, et al. Access to social protection by people living with, at risk of, or affected by HIV in Eswatini, Malawi, Tanzania, and Zambia: Results from population-based HIV impact assessments. AIDS Behav. 2022;26(9):3068–78.CrossRefPubMedPubMedCentral
7.
go back to reference Hladik W, Barker J, Ssenkusu JM, Opio A, Tappero JW, Hakim A, Serwadda D. HIV infection among men who have sex with men in Kampala, Uganda–a respondent driven sampling survey. PLoS ONE. 2012;7(5): e38143.CrossRefPubMedPubMedCentral Hladik W, Barker J, Ssenkusu JM, Opio A, Tappero JW, Hakim A, Serwadda D. HIV infection among men who have sex with men in Kampala, Uganda–a respondent driven sampling survey. PLoS ONE. 2012;7(5): e38143.CrossRefPubMedPubMedCentral
8.
go back to reference Vu L, Andrinopoulos K, Tun W, Adebajo S. High levels of unprotected anal intercourse and never testing for HIV among men who have sex with men in Nigeria: evidence from a cross-sectional survey for the need for innovative approaches to HIV prevention. Sex Transm Infect. 2013;89(8):659–65.CrossRefPubMed Vu L, Andrinopoulos K, Tun W, Adebajo S. High levels of unprotected anal intercourse and never testing for HIV among men who have sex with men in Nigeria: evidence from a cross-sectional survey for the need for innovative approaches to HIV prevention. Sex Transm Infect. 2013;89(8):659–65.CrossRefPubMed
9.
go back to reference Park JN, Papworth E, Kassegne S, Moukam L, Billong SC, Macauley I, et al. HIV prevalence and factors associated with HIV infection among men who have sex with men in Cameroon. J Int AIDS Soc. 2013;16:18752.CrossRefPubMedPubMedCentral Park JN, Papworth E, Kassegne S, Moukam L, Billong SC, Macauley I, et al. HIV prevalence and factors associated with HIV infection among men who have sex with men in Cameroon. J Int AIDS Soc. 2013;16:18752.CrossRefPubMedPubMedCentral
10.
go back to reference Augustinavicius JL, Baral SD, Murray SM, Jackman K, Xue Q-L, Sanchez TH, et al. Characterizing Cross-Culturally Relevant Metrics of Stigma Among Men Who Have Sex With Men Across 8 Sub-Saharan African Countries and the United States. Am J Epidemiol. 2020;189(7):690–7.CrossRefPubMedPubMedCentral Augustinavicius JL, Baral SD, Murray SM, Jackman K, Xue Q-L, Sanchez TH, et al. Characterizing Cross-Culturally Relevant Metrics of Stigma Among Men Who Have Sex With Men Across 8 Sub-Saharan African Countries and the United States. Am J Epidemiol. 2020;189(7):690–7.CrossRefPubMedPubMedCentral
11.
go back to reference Yang X, Yu Y, Song X, He L, Fu Y, Zhang J, et al. Prevalence of unprotected anal intercourse and associated factors among male students who have sex with men in Qingdao, China: a cross-sectional study. Medicine. 2023;102(9):e33180. Yang X, Yu Y, Song X, He L, Fu Y, Zhang J, et al. Prevalence of unprotected anal intercourse and associated factors among male students who have sex with men in Qingdao, China: a cross-sectional study. Medicine. 2023;102(9):e33180.
12.
go back to reference Queiroz AAFLN, Sousa ÁFLd, Araújo TMEd, RK Reis, I Fronteira, MEB Moura. High rates of unprotected receptive anal sex and vulnerabilities to HIV infection among Brazilian men who have sex with men. Int J STD AIDS. 2021;32(4):368–77.CrossRefPubMed Queiroz AAFLN, Sousa ÁFLd, Araújo TMEd, RK Reis, I Fronteira, MEB Moura. High rates of unprotected receptive anal sex and vulnerabilities to HIV infection among Brazilian men who have sex with men. Int J STD AIDS. 2021;32(4):368–77.CrossRefPubMed
13.
go back to reference Martins AdA, Queiroz AAFLN, Frota OP, Araújo TMEd, Mendes IAC, Fronteira I, Sousa ÁFLd. Consumption of sexually explicit media and unprotected anal sex in men who have sex with men. Cien Saude Colet. 2021;26:5841–9.CrossRefPubMed Martins AdA, Queiroz AAFLN, Frota OP, Araújo TMEd, Mendes IAC, Fronteira I, Sousa ÁFLd. Consumption of sexually explicit media and unprotected anal sex in men who have sex with men. Cien Saude Colet. 2021;26:5841–9.CrossRefPubMed
14.
go back to reference Caballero-Hoyos R, Monárrez-Espino J, Ramírez-Ortíz MG, Cárdenas-Medina FM. Factors Associated with Unprotected Anal Sex among Men Who Have Sex with Men in Mexico. Infectious Disease Reports. 2022;14(4):547–57.CrossRefPubMedPubMedCentral Caballero-Hoyos R, Monárrez-Espino J, Ramírez-Ortíz MG, Cárdenas-Medina FM. Factors Associated with Unprotected Anal Sex among Men Who Have Sex with Men in Mexico. Infectious Disease Reports. 2022;14(4):547–57.CrossRefPubMedPubMedCentral
15.
go back to reference Platt L, French CE, McGowan CR, Sabin K, Gower E, Trickey A, et al. Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta-analysis. J Viral Hepatitis. 2020;27(3):294–315.CrossRef Platt L, French CE, McGowan CR, Sabin K, Gower E, Trickey A, et al. Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta-analysis. J Viral Hepatitis. 2020;27(3):294–315.CrossRef
16.
go back to reference Mutagoma M, Balisanga H, Malamba SS, Sebuhoro D, Remera E, Riedel DJ, et al. Hepatitis B virus and HIV co-infection among pregnant women in Rwanda. BMC Infect Dis. 2017;17(1):1–7. Mutagoma M, Balisanga H, Malamba SS, Sebuhoro D, Remera E, Riedel DJ, et al. Hepatitis B virus and HIV co-infection among pregnant women in Rwanda. BMC Infect Dis. 2017;17(1):1–7.
17.
go back to reference Mutagoma M, Balisanga H, Sebuhoro D, Mbituyumuremyi A, Remera E, Malamba SS, et al. Hepatitis C virus and HIV co-infection among pregnant women in Rwanda. BMC Infect Dis. 2017;17(1):167.CrossRefPubMedPubMedCentral Mutagoma M, Balisanga H, Sebuhoro D, Mbituyumuremyi A, Remera E, Malamba SS, et al. Hepatitis C virus and HIV co-infection among pregnant women in Rwanda. BMC Infect Dis. 2017;17(1):167.CrossRefPubMedPubMedCentral
18.
go back to reference Nsanzimana S, Rwibasira GN, Malamba SS, Musengimana G, Kayirangwa E, Jonnalagadda S, et al. HIV incidence and prevalence among adults aged 15–64 years in Rwanda: results from the Rwanda Population-based HIV Impact Assessment (RPHIA) and District-level Modeling, 2019. Int J Infect Dis. 2022;116:245–54. Nsanzimana S, Rwibasira GN, Malamba SS, Musengimana G, Kayirangwa E, Jonnalagadda S, et al. HIV incidence and prevalence among adults aged 15–64 years in Rwanda: results from the Rwanda Population-based HIV Impact Assessment (RPHIA) and District-level Modeling, 2019. Int J Infect Dis. 2022;116:245–54.
20.
go back to reference Hahné SJ, Veldhuijzen IK, Wiessing L, Lim T-A, Salminen M, Laar Mvd. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis. 2013;13:1–16.CrossRef Hahné SJ, Veldhuijzen IK, Wiessing L, Lim T-A, Salminen M, Laar Mvd. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis. 2013;13:1–16.CrossRef
21.
go back to reference Cardona-Arias JA, Correa JCC, Higuita-Gutiérrez LF. Prevalence of hepatitis B/C viruses and associated factors in key groups attending a health services institution in Colombia, 2019. PLoS ONE. 2020;15(9): e0238655.CrossRefPubMedPubMedCentral Cardona-Arias JA, Correa JCC, Higuita-Gutiérrez LF. Prevalence of hepatitis B/C viruses and associated factors in key groups attending a health services institution in Colombia, 2019. PLoS ONE. 2020;15(9): e0238655.CrossRefPubMedPubMedCentral
22.
go back to reference Maponga TG, Matteau Matsha R, Morin S, Scheibe A, Swan T, Andrieux-Meyer I, et al. Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting-HIV/viral hepatitis: improving diagnosis, antiviral therapy and access. Hepatology, Medicine and Policy. 2017;2:1–9.CrossRef Maponga TG, Matteau Matsha R, Morin S, Scheibe A, Swan T, Andrieux-Meyer I, et al. Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting-HIV/viral hepatitis: improving diagnosis, antiviral therapy and access. Hepatology, Medicine and Policy. 2017;2:1–9.CrossRef
23.
go back to reference Singh KP, Crane M, Audsley J, Lewin SR. HIV-Hepatitis B virus co-infection: epidemiology, pathogenesis and treatment. AIDS (London, England). 2017;31(15):2035.CrossRefPubMed Singh KP, Crane M, Audsley J, Lewin SR. HIV-Hepatitis B virus co-infection: epidemiology, pathogenesis and treatment. AIDS (London, England). 2017;31(15):2035.CrossRefPubMed
24.
go back to reference Nsanzimana S, Prabhu K, McDermott H, Karita E, Forrest JI, Drobac P, et al. Improving health outcomes through concurrent HIV program scale-up and health system development in Rwanda: 20 years of experience. BMC Med. 2015;13:216.CrossRefPubMedPubMedCentral Nsanzimana S, Prabhu K, McDermott H, Karita E, Forrest JI, Drobac P, et al. Improving health outcomes through concurrent HIV program scale-up and health system development in Rwanda: 20 years of experience. BMC Med. 2015;13:216.CrossRefPubMedPubMedCentral
25.
go back to reference Nsanzimana S, Kanters S, Remera E, Forrest JI, Binagwaho A, Condo J, Mills EJ. HIV care continuum in Rwanda: a cross-sectional analysis of the national programme. The lancet HIV. 2015;2(5):e208–15.CrossRefPubMed Nsanzimana S, Kanters S, Remera E, Forrest JI, Binagwaho A, Condo J, Mills EJ. HIV care continuum in Rwanda: a cross-sectional analysis of the national programme. The lancet HIV. 2015;2(5):e208–15.CrossRefPubMed
26.
go back to reference Nsanzimana S, Remera E, Kanters S, Chan K, Forrest JI, Ford N, et al. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study. Lancet Glob Health. 2015;3(3):e169–77.CrossRefPubMed Nsanzimana S, Remera E, Kanters S, Chan K, Forrest JI, Ford N, et al. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study. Lancet Glob Health. 2015;3(3):e169–77.CrossRefPubMed
27.
go back to reference JO TR, Herbst S, Hamill MM, Liestman B, Nyombayire J, Lyons CE, et al. Cross-sectional assessment of determinants of STIs among men who have sex with men and transgender women in Kigali, Rwanda. Sex Transm Infec. 2021;98(3):178–87. JO TR, Herbst S, Hamill MM, Liestman B, Nyombayire J, Lyons CE, et al. Cross-sectional assessment of determinants of STIs among men who have sex with men and transgender women in Kigali, Rwanda. Sex Transm Infec. 2021;98(3):178–87.
28.
go back to reference Mutagoma M, Samuel MS, Kayitesi C, Gasasira AR, Chitou B, Boer K, et al. High HIV prevalence and associated risk factors among female sex workers in Rwanda. Int J STD AIDS. 2017;28(11):1082–9.CrossRefPubMedPubMedCentral Mutagoma M, Samuel MS, Kayitesi C, Gasasira AR, Chitou B, Boer K, et al. High HIV prevalence and associated risk factors among female sex workers in Rwanda. Int J STD AIDS. 2017;28(11):1082–9.CrossRefPubMedPubMedCentral
29.
go back to reference Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174–99.CrossRef Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174–99.CrossRef
30.
go back to reference Tuyishime E, Kayitesi C, Musengimana G, Malamba S, Moges H, Kankindi I, et al. Population Size Estimation of Men Who Have Sex With Men in Rwanda: Three-Source Capture-Recapture Method. JMIR Public Health Surveill. 2023;9: e43114.CrossRefPubMedPubMedCentral Tuyishime E, Kayitesi C, Musengimana G, Malamba S, Moges H, Kankindi I, et al. Population Size Estimation of Men Who Have Sex With Men in Rwanda: Three-Source Capture-Recapture Method. JMIR Public Health Surveill. 2023;9: e43114.CrossRefPubMedPubMedCentral
31.
go back to reference Handcock MS, Fellows IE, Gile KJ. RDS Analyst: Software for the analysis of Respondent-Driven Sampling data. Version 042. 2014. Handcock MS, Fellows IE, Gile KJ. RDS Analyst: Software for the analysis of Respondent-Driven Sampling data. Version 042. 2014.
32.
go back to reference Pinzon E, editor. Differences-in-differences in Stata 17. London Stata Conference 2021; 2021: Stata Users Group. Pinzon E, editor. Differences-in-differences in Stata 17. London Stata Conference 2021; 2021: Stata Users Group.
33.
go back to reference Nelson NP, Easterbrook PJ, McMahon BJ. Epidemiology of hepatitis B virus infection and impact of vaccination on disease. Clin Liver Dis. 2016;20(4):607–28.CrossRefPubMedPubMedCentral Nelson NP, Easterbrook PJ, McMahon BJ. Epidemiology of hepatitis B virus infection and impact of vaccination on disease. Clin Liver Dis. 2016;20(4):607–28.CrossRefPubMedPubMedCentral
34.
go back to reference Organization WH. Global hepatitis report 2017: World Health Organization; 2017. Organization WH. Global hepatitis report 2017: World Health Organization; 2017.
35.
go back to reference Center RB. Rwanda Population-based HIV Impact Assessment (RPHIA) 2018–2019: Final Report. Kigali: RBC; 2020. Center RB. Rwanda Population-based HIV Impact Assessment (RPHIA) 2018–2019: Final Report. Kigali: RBC; 2020.
37.
go back to reference Thrift AP, El-Serag HB, Kanwal F. Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol. 2017;14(2):122–32.CrossRefPubMed Thrift AP, El-Serag HB, Kanwal F. Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol. 2017;14(2):122–32.CrossRefPubMed
38.
go back to reference (NISR) NIoSoR. 5th Rwanda Population and Housing Census (PHC). 2022. (NISR) NIoSoR. 5th Rwanda Population and Housing Census (PHC). 2022.
39.
go back to reference Beyrer C, Sullivan P, Sanchez J, Baral SD, Collins C, Wirtz AL, et al. The increase in global HIV epidemics in MSM. AIDS. 2013;27(17):2665–78.CrossRefPubMed Beyrer C, Sullivan P, Sanchez J, Baral SD, Collins C, Wirtz AL, et al. The increase in global HIV epidemics in MSM. AIDS. 2013;27(17):2665–78.CrossRefPubMed
40.
go back to reference Snyder LB. Health communication campaigns and their impact on behavior. J Nutr Educ Behav. 2007;39(2):S32–40.CrossRefPubMed Snyder LB. Health communication campaigns and their impact on behavior. J Nutr Educ Behav. 2007;39(2):S32–40.CrossRefPubMed
41.
go back to reference Rwanda NIoSo. Labour Force Survey Trends, May 2023 report Rwanda NIoSo. Labour Force Survey Trends, May 2023 report
42.
go back to reference Melendez-Torres G, Bourne A. Illicit drug use and its association with sexual risk behaviour among MSM: more questions than answers? Curr Opin Infect Dis. 2016;29(1):58–63.CrossRefPubMed Melendez-Torres G, Bourne A. Illicit drug use and its association with sexual risk behaviour among MSM: more questions than answers? Curr Opin Infect Dis. 2016;29(1):58–63.CrossRefPubMed
43.
go back to reference Lin Y, Gao Y, Sun Y, Turner D, Zou H, Vermund SH, Qian H-Z. Does Voluntary Medical Male Circumcision Reduce HIV Risk in Men Who Have Sex with Men? Curr HIV/AIDS Rep. 2022;19(6):522–5.CrossRefPubMed Lin Y, Gao Y, Sun Y, Turner D, Zou H, Vermund SH, Qian H-Z. Does Voluntary Medical Male Circumcision Reduce HIV Risk in Men Who Have Sex with Men? Curr HIV/AIDS Rep. 2022;19(6):522–5.CrossRefPubMed
Metadata
Title
HIV and hepatitis B, C co-infection and correlates of HIV infection among men who have sex with men in Rwanda, 2021: a respondent-driven sampling, cross-sectional study
Authors
Eric Remera
Elysee Tuyishime
Catherine Kayitesi
Samuel S. Malamba
Beata Sangwayire
Justine Umutesi
Horacio Ruisenor-Escudero
Tom Oluoch
Publication date
01-12-2024

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine